U.S. Dementia Treatment Market Size & Outlook, 2023-2030
U.S. dementia treatment market, 2018-2030 (US$M)
Related Markets
U.S. dementia treatment market highlights
- The U.S. dementia treatment market generated a revenue of USD 5,972.9 million in 2023 and is expected to reach USD 9,290.6 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.5% from 2024 to 2030.
- In terms of segment, alzheimer’s disease dementia was the largest revenue generating indication in 2023.
- Lewy Body Dementia is the most lucrative indication segment registering the fastest growth during the forecast period.
Dementia treatment market data book summary
| Market revenue in 2023 | USD 5,972.9 million |
| Market revenue in 2030 | USD 9,290.6 million |
| Growth rate | 6.5% (CAGR from 2023 to 2030) |
| Largest segment | Alzheimer’s disease dementia |
| Fastest growing segment | Lewy Body Dementia |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Alzheimer’s Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia (FTD), Parkinson Disease Dementia, Other Indications |
| Key market players worldwide | Eisai Co Ltd, Eli Lilly and Co, Novartis AG ADR, Daiichi Sankyo Co Ltd, AbbVie Inc, H. Lundbeck AS Class A, Biogen Inc, Cipla Ltd DR, Sun Pharmaceutical Industries, Viatris Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 35.0% of the global dementia treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. dementia treatment market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 835.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dementia Treatment Market Scope
Dementia Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. dementia treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dementia treatment market will help companies and investors design strategic landscapes.
Alzheimer’s disease dementia was the largest segment with a revenue share of 60.08% in 2023. Horizon Databook has segmented the U.S. dementia treatment market based on alzheimer’s disease dementia, vascular dementia, lewy body dementia, frontotemporal dementia (ftd), parkinson disease dementia, other indications covering the revenue growth of each sub-segment from 2018 to 2030.
The dementia treatment market in the U.S. dominated the North America market with a revenue share of 83.5% in 2024, aided by a strong presence of key players, better reimbursement policies, improved healthcare infrastructure, and favorable initiatives undertaken by government & non-government bodies to improve the healthcare services for dementia patients.
For instance, in October 2023, U.S.-based CuraSen Therapeutics announced the initiation of a human clinical trial with a new neurodegenerative disease drug, CST-3056 in the 4th quarter of 2024. The company has received funding of USD 5.8 million from the Alzheimer’s Drug Discovery Foundation.
Reasons to subscribe to U.S. dementia treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. dementia treatment market databook
-
Our clientele includes a mix of dementia treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. dementia treatment market, including forecasts for subscribers. This country databook contains high-level insights into U.S. dementia treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. dementia treatment market report size, by indication, 2018-2030 (US$M)
U.S. Dementia Treatment Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
